Similar articles

• The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.

  Doi T, Mima A, Matsubara T, Tominaga T, Arai H, Abe H. Doi T, et al. Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S21-4. doi: 10.1016/j.diabres.2008.09.013. Epub 2008 Oct 7. Diabetes Res Clin Pract. 2008. PMID: 18842318
• The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy.

  Chen C, Lin J, Li L, Zhu T, Gao L, Wu W, Liu Q, Ou S. Chen C, et al. Life Sci. 2019 Mar 1;220:106-116. doi: 10.1016/j.lfs.2019.01.049. Epub 2019 Jan 29. Life Sci. 2019. PMID: 30708099
• Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.

  Mima A, Arai H, Matsubara T, Abe H, Nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T. Mima A, et al. Diabetes. 2008 Jun;57(6):1712-22. doi: 10.2337/db07-1726. Epub 2008 Feb 19. Diabetes. 2008. PMID: 18285555
• [Diabetic nephropathy: diagnostic criteria and staging].

  Haneda M. Haneda M. Nihon Rinsho. 2005 Jun;63 Suppl 6:320-3. Nihon Rinsho. 2005. PMID: 15999727 Review. Japanese. No abstract available.
• Role of the JAK/STAT signaling pathway in diabetic nephropathy.

  Marrero MB, Banes-Berceli AK, Stern DM, Eaton DC. Marrero MB, et al. Am J Physiol Renal Physiol. 2006 Apr;290(4):F762-8. doi: 10.1152/ajprenal.00181.2005. Am J Physiol Renal Physiol. 2006. PMID: 16527921 Review.